T2 diabetes Flashcards
MOA Biguanide
Increases peripheral sensitivity to insulin by activating AMP protein kinase
Metformin
MOA DPP4
Inhibits degradation of incretin
Incretin:
- stimulates insulin secretion
- inhibits glucagon release
- delays gastric emptying
GLIPTINS
MOA GLP1 receptor agonist
Binds to GLP1 receptor to promote insulin release
suppresses elevated glucagon
Delays gastric emptying
Stimulates Beta cell regeneration and differentiation in vitro
UTIDES
MOA SGLT2
Increases urinary glucose secretion from proximal convoluted tubule
OZINS
MOA Sulfonureas
Increases insulin production by closing potassium channels, up-regulating calcium mediated release of insulin.
MOA Meglitonides
Increases Beta cell insulin release by closing Potassium channels , up-regulating calcium mediated release of insulin. They bind to a different part of the receptor to Sulfonureas.
drug classes that are insulin secretatogues
Meglitonides
Sulfoureas
MOA Thiazolidinediones
Bind to PPARgamma in adipose tissue to promote adipogenesis and fatty acid uptake.
This sensitizes the tissues to insulin
MOA Alpha glucosidase inhibitors
Slows carbohydrate digestion by inhibiting brush border alpha glucosides
Acarbose
Diabetic medications which increase risk of hypoglycemia
Meglitonides
sulfonureas
insulin
Diabetic medications to be held when dehydrated
SGLT2
Metformin
Sulfonureas
(ACEi, diuretics, ARB, NSAIDs
Diabetic medications to aid with weight loss
GLP1 receptor agonists
SGLT2
Metformin
Diabetic medications safe for eGFR<15
Alogliptin at 6.25mg dose Sitagliptin at 25mg dose linagliptin Dulaglutide repaglinide Pioglitazone Rosiglitazone Insulin
Diabetic medications which improve CVD
SGLT2
Liraglutide
Metformin (reduction in MiI in overweight)
Diabetic medications safe in pregnancy
Metformin
Insulin